KRW

2-{4-[1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL]-1H-PYRAZOL-1-YL}ETHANOL

Created:	2011-08-16
Last modified:	2014-09-05

Find Related PDB Entry
1 entries where KRW is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	0
Bond Count	48
Aromatic Bond Count	26

2D diagram of KRW

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-{4-[1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL]-1H-PYRAZOL-1-YL}ETHANOL
Systematic Name (OpenEye OEToolkits)	2-[4-[3-(quinolin-6-ylmethyl)-[1,2,3]triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol
Formula	C₁₉ H₁₆ N₈ O
Molecular Weight	372.383
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OCCn5ncc(c1nc2c(nc1)nnn2Cc4cc3cccnc3cc4)c5
SMILES	CACTVS	3.385	OCCn1cc(cn1)c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2
SMILES	OpenEye OEToolkits	1.9.2	c1cc2cc(ccc2nc1)Cn3c4c(ncc(n4)c5cnn(c5)CCO)nn3
Canonical SMILES	CACTVS	3.385	OCCn1cc(cn1)c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1cc2cc(ccc2nc1)Cn3c4c(ncc(n4)c5cnn(c5)CCO)nn3
InChI	InChI	1.03	InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2
InChIKey	InChI	1.03	PDMUGYOXRHVNMO-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB12848
Name	PF-04217903
Groups	investigational
Description	PF-04217903 has been used in trials studying the treatment of Neoplasms.
Synonyms	PF-04217903
CAS number	956905-27-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2001019
PubChem	17754438
ChEMBL	CHEMBL2001019
ChEBI	CHEBI:91425

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.